Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Hexavalent vs Pentavalent+IPV Schedules in Infants
NCT06748612Phase 4Not yet recruiting
- Sponsor
- icddr,b
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Modality
- Prophylactic Vaccines
01
Overview
A Phase 4 trial of Hexavalent Vaccine in poliomyelitis, sponsored by icddr,b. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
Hexavalent Vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT06748612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06748612.